Correction to: Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia

Lignende værker

• Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia
  af: Misra, V. P., et al.
  Udgivet: (2020)
• Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice
  af: Trosch, Richard M., et al.
  Udgivet: (2020)
• OnabotulinumtoxinA and AbobotulinumtoxinA Dose Conversion: A Systematic Literature Review
  af: Dashtipour, Khashayar, et al.
  Udgivet: (2015)
• Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies
  af: Misra, Vijay P., et al.
  Udgivet: (2018)
• Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom
  af: Muthukumar M, et al.
  Udgivet: (2017-04-01)